Thomas Jacxsens, Vice President of Bayer Healthcare, remarked that China's opening-up policies—such as the action plan to stabilize foreign investments and invite foreign enterprises to participate in bio programs—are reassuring, during an exclusive interview with People's Daily. In this episode of China Opportunities, he also noted that Beijing is an ideal location due to its available talent and seamless supplier integration. The German pharmaceutical giant also praised China's efforts to develop new quality productive forces, which present significant opportunities. (Produced by Shan Xin, Li Yuanxin, Zheng Qi, Li Jianguang, Wang Zhou and interns Shan Yiying, Li Mengyang and Ying Zhe)